Diagnostic screening programs help catch cancer, abnormalities or other diseases before they reach an advanced stage, saving lives and healthcare costs. Screening programs include, lung, breast, prostate, and cervical cancer, among many others.
There are no standards requiring radiologists to report on the presence of BACs, even though up to half of referring providers have indicated they would prefer to be made aware of the finding.
Despite the great progress that has been made toward the clinical implementation of AI, new data caution against trusting the technology as a single reader in certain settings.
The ACR hopes these changes, including the addition of diagnostic performance feedback, will help reduce the number of patients with incidental nodules lost to follow-up each year.
An innovative chip design that could increase the portability and lower the cost of currentmedical ultrasound equipment is the winner of the first phase of the System-on-a-Chip Design Contest sponsored by Semiconductor Research Corporation and the Semico
We may be on the dawn of a new era in medical imaging, according to two just-published peer-reviewed international journals, Kybernetes and Functional Diagnostics.
UltraRAD Corporation has announced that it has licensed orthopedic tools and templates packages from Cedara in a move to enter into the orthopedic market with its UltraORTHO line, the company said.
Varian Medical Systems, Inc. used this week's American Society for Therapeutic Radiology and Oncology's annual meeting in Denver as the launching pad of its new ARIA oncology information management system.
Breast MRI is a useful tool in the detection of microscopic lesions within the breast, according to a study presented Monday at the American Society for Therapeutic Radiology and Oncology's annual meeting in Denver.
For the first time, Eastman Kodak Co. is generating more sales from digital imaging than from film-based photography, yet that change resulted in a $1.03 billion loss in the third quarter largely due to one-time tax charges.
Clinicians have been using HeartSee to diagnose and treat coronary artery disease since the technology first debuted back in 2018. These latest updates, set to roll out to existing users, are designed to improve diagnostic performance and user access.
The cardiac technologies clinicians use for CVD evaluations have changed significantly in recent years, according to a new analysis of CMS data. While some modalities are on the rise, others are being utilized much less than ever before.
